🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial studies the side effects and best dose of melphalan w...
Status
Unknown
Location
University of Minnesota/Masonic Cancer Center
Start Date
2009-07-09
Trial ID
NCT00983398
This phase I trial studies the best dose and side effects of mephalan in tr...
Status
Recruiting
Location
Winship Cancer Institute of Emory University
Start Date
2021-05-20
Trial ID
NCT04483206
Treatments Being Tested
This randomized phase III trial studies 90-yttrium ibritumomab tiuxetan and...
Status
Terminated
Location
City of Hope Medical Center
Start Date
2015-01
Trial ID
NCT02366663
RATIONALE: Giving chemotherapy, such as clofarabine, melphalan, and thiotep...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-11-20
Trial ID
NCT00423514
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Status
Completed
Location
CCOP - Scottsdale Oncology Program
Start Date
1994-01
Trial ID
NCT00002548
This is a study of a regimen of melphalan and autologous stem cells for pat...
Status
Completed
Location
Masonic Cancer Center, University of Minnesota
Start Date
2004-04-20
Trial ID
NCT00177047
Treatments Being Tested
This is a phase II prospective non-randomised clinical trial in newly diagn...
Status
Completed
Location
Aarhus University Hospital
Start Date
2001-10
Trial ID
NCT00791947
Treatments Being Tested
This clinical trial is for men and women with whose lymphoma (non-Hodgkin o...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2014-06-04
Trial ID
NCT02059239
Amyloidosis results from tissue deposition of amyloid protein, composed mai...
Status
Completed
Location
CHRU d'Amiens
Start Date
2008-01
Trial ID
NCT00621400
Treatments Being Tested
The marked activity of thalidomide (thal) and dexamethasone (dex) in relaps...
Status
Completed
Location
Multiple Locations
Start Date
2002-03
Trial ID
NCT01341262
Treatments Being Tested